Keros Therapeutics, Inc.
KROS· Nasdaq
Keros Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · -1.14%
- Market cap
- $223.06M
- 19.83M shares
- Filings
- 532
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $244,061,000 | reported | |
| FY 2024 | 2024-12-31 | $3,550,000 | reported | |
| FY 2023 | 2023-12-31 | $151,000 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $20,100,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $10,000,000 | reported |
Keros Therapeutics, Inc. · CIK 1664710 · Engraved from SEC EDGAR
